Sunflower: Progress is being made on the major asset restructuring.

Sunflower announcement: The company plans to acquire 100% equity of Zhangzhou Xipu Material Technology Co., Ltd. and 40% equity of Zhejiang Beide Pharmaceutical Co., Ltd. through share issuance and cash payment, and raise supporting funds, forming a major asset restructuring. The company's stock has been suspended from trading since September 8, 2025, and resumed trading on September 22. As of the disclosure date of this announcement, the audit, evaluation, due diligence, and other related work for this transaction are being carried out orderly, and the company is continuing to communicate and negotiate with relevant parties. The transaction still needs to be approved by the board of directors and shareholders' meeting, and can only be implemented after approval by the competent regulatory authorities, with uncertainties.